University of Siena

Running trials

• Recruiting

  MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.

  NCT07092670· Intergruppo Melanoma Italiano· Source

• Active, not recruiting

  Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study)

  NCT05575167· 424 General Military Hospital· Source

• Recruiting

  Sequential Therapies After Osteoanabolic Treatment

  NCT06164795· 424 General Military Hospital· Source

• Active, not recruiting

  Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive Tool

  NCT06550037· Alessio Fasano· Source

• Recruiting

  A ProspeCtive mUlticenteR Investigation on RENzar Stent Safety and Efficacy in the Treatment of Patients With Femoro-popliteal Disease in Tuscany (CURRENT Registry)

  NCT05701293· Azienda Ospedaliera Universitaria Senese· Source

• Recruiting

  Type 2 Diabetes, Obesity and Cortisol Excess

  NCT05759637· Istituto Auxologico Italiano· Source

• Recruiting

  ALTo endogrAft Italian Registry

  NCT05234892· Gianmarco de Donato· Source

• Recruiting

  Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

  NCT05430828· Federico II University· Source

• Recruiting

  Standard Versus Super-extended Lymphadenectomy After Neo-adjuvant Chemotherapy for Gastric Cancer

  NCT03961373· Phase 3· University of Siena· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Aortic aneurysm1 recruiting
• Childhood cancers1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Melanoma1 recruiting
• Obesity1 recruiting
• Osteoporosis1 recruiting
• Peripheral artery disease1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

  NCT05841030· Janssen Research & Development, LLC· Source

• Terminated

  A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients

  NCT06025110· Phase 2· ITB-Med LLC· Source

• Completed

  Comprehensive Ultrasound Evaluation as a Predictor of Weaning

  NCT05539599· Università degli Studi di Ferrara· Source

• Completed

  TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study

  NCT01860456· University of Pisa· Source

• Completed

  ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry)

  NCT01534819· Medtronic Cardiovascular· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Melanoma47 works · 1 trial
• Multiple sclerosis38 works · 0 trials
• Psoriasis20 works · 0 trials
• Sarcoidosis13 works · 0 trials
• Amyloidosis13 works · 0 trials
• Endometriosis13 works · 0 trials
• Psoriatic arthritis12 works · 0 trials
• Myocarditis12 works · 0 trials
• Vitiligo9 works · 0 trials
• Chronic myeloid leukaemia8 works · 1 trial
• Hidradenitis suppurativa7 works · 0 trials
• Keratoconus6 works · 0 trials
• Chronic lymphocytic leukaemia6 works · 0 trials
• Burkitt lymphoma5 works · 0 trials
• Mesothelioma5 works · 0 trials
• Alopecia areata4 works · 0 trials
• Giant cell arteritis3 works · 0 trials
• Primary biliary cholangitis3 works · 0 trials
• Uterine fibroids3 works · 0 trials